Connaughton Bernadette — SEC Form 4 filings
SEC reporting owner CIK 1662521. 15 Form 4 filings on record with FilingPulse; latest filed 2026-08-11.
Transaction summary — filings shown
Covers all 15 filings on record, filed 2024-04-29 to 2026-08-11. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 13 legs across 9 filings — 17,330 shares, $1,284,583 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 9.
- Largest priced transaction: sale of 2,977 shares @ $73.62 ($219,161) in HALOZYME THERAPEUTICS, INC., filed 2025-09-02.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| HALOZYME THERAPEUTICS, INC. (HALO) | Director | 12 | — | 13 legs · 17,330 sh · $1,284,583 | 6 |
| Editas Medicine, Inc. (EDIT) | Director | 3 | — | — | 3 |
Form 4 filings — Connaughton Bernadette
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-11 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Sale (S): 1,626 @ $102.80 | EDGAR |
| 2026-07-02 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Sale (S): 1,000 @ $76.39 · Sale (S): 625 @ $77.21 | EDGAR |
| 2026-06-22 | 4 | Editas Medicine, Inc. (EDIT) | Grant/award (A): 51,700 (derivative) @ $0 | EDGAR |
| 2026-06-02 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Sale (S): 1,625 @ $66.21 | EDGAR |
| 2026-05-07 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Grant/award (A): 6,796 @ $0 · Grant/award (A): 6,040 (derivative) @ $0 | EDGAR |
| 2026-05-05 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Sale (S): 1,625 @ $63.48 | EDGAR |
| 2026-01-06 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Sale (S): 2,000 @ $70.25 | EDGAR |
| 2025-12-01 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Sale (S): 829 @ $71.60 | EDGAR |
| 2025-11-12 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Sale (S): 2,000 @ $68.48 | EDGAR |
| 2025-10-01 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Sale (S): 1,500 @ $75.09 · Sale (S): 500 @ $75.70 | EDGAR |
| 2025-09-02 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Sale (S): 100 @ $71.71 · Sale (S): 2,977 @ $73.62 · Sale (S): 923 @ $74.11 | EDGAR |
| 2025-06-10 | 4 | Editas Medicine, Inc. (EDIT) | Grant/award (A): 37,500 (derivative) @ $0 | EDGAR |
| 2025-05-02 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Grant/award (A): 4,165 @ $0 · Grant/award (A): 5,750 (derivative) @ $0 | EDGAR |
| 2024-06-03 | 4 | Editas Medicine, Inc. (EDIT) | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2024-04-29 | 4 | HALOZYME THERAPEUTICS, INC. (HALO) | Grant/award (A): 6,501 @ $0 · Grant/award (A): 8,804 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1662521 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →